Advertisement
New Zealand markets closed
  • NZX 50

    11,699.79
    -28.27 (-0.24%)
     
  • NZD/USD

    0.6118
    -0.0004 (-0.06%)
     
  • NZD/EUR

    0.5634
    +0.0005 (+0.09%)
     
  • ALL ORDS

    8,082.30
    -67.80 (-0.83%)
     
  • ASX 200

    7,814.40
    -66.90 (-0.85%)
     
  • OIL

    79.41
    +0.18 (+0.23%)
     
  • GOLD

    2,406.90
    +21.40 (+0.90%)
     
  • NASDAQ

    18,557.96
    -38.69 (-0.21%)
     
  • FTSE

    8,415.90
    -22.75 (-0.27%)
     
  • Dow Jones

    39,869.38
    -38.62 (-0.10%)
     
  • DAX

    18,694.14
    -44.67 (-0.24%)
     
  • Hang Seng

    19,553.61
    +177.08 (+0.91%)
     
  • NIKKEI 225

    38,787.38
    -132.88 (-0.34%)
     
  • NZD/JPY

    95.2340
    +0.1730 (+0.18%)
     

AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales

AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales

Fears that Humira biosimilars will erode AbbVie's topline are overblown, an analyst said Monday. He has an outperform rating on AbbVie stock.